Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2002-05-01
2008-12-16
Blanchard, David J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C514S012200, C530S324000, C530S387300, C435S007230, C435S069100, C435S069600
Reexamination Certificate
active
07465785
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 5546637 (1996-08-01), Niedecker
patent: 6025156 (2000-02-01), Gwynn et al.
patent: 6124433 (2000-09-01), Falb et al.
patent: 6156500 (2000-12-01), Falb
patent: 6162604 (2000-12-01), Jacob
patent: 6204371 (2001-03-01), Levinson
patent: 6228582 (2001-05-01), Rodier et al.
patent: 6395306 (2002-05-01), Cui et al.
patent: 6414117 (2002-07-01), Levinson
patent: 6465185 (2002-10-01), Goldfine et al.
patent: 6498235 (2002-12-01), Sheppard et al.
patent: 6534641 (2003-03-01), Falb et al.
patent: 6562343 (2003-05-01), Levinson
patent: 6645499 (2003-11-01), Lal et al.
patent: 6730502 (2004-05-01), Van Hijum et al.
patent: 6737522 (2004-05-01), Sundick et al.
patent: WO 97/38085 (1997-10-01), None
patent: WO 01/53312 (2001-07-01), None
Hu et al. (2003, Journal of Proteome Research 2:405-412.
Haynes et al. (1998, Electrophoresis 1921862-1871.
Burgess et al, Journal of Cell Biology vol. 111 Nov. 1990 2129-2138.
Lazar et al Molecular and Cellular Biology Mar. 1988 vol. 8 No. 3 1247-1252.
Schwartz et al, Proc Natl Acad Sci USA vol. 84:6408-6411 (1987.
Lin et al Biochemistry USA vol. 14:1559-1563 (1975.
Fu et al (EMBO Journal, 1996, vol. 15, pp. 4392-4401.
Powell et al (Pharmacogenesis, 1998, vol. 8, pp. 411-421, abstract.
Vallejo et al (Biochimie, 2000, vol. 82, pp. 1129-1133, abstract.
Pennica et al (PNAS 95:14717-22, 1998.
Jang et al (Clinical and Experimental Metastasis, 1997, vol. 15, pp. 469-483, abstract.
Gokmen-Polar et al Cancer Res 61:1375-1381, 2001.
Crick F. Nature 227:561-563, 1970.
Greenbaum et al. Genome Biology, 4(9):117.1-117.8, 2003.
Lian et al. Blood 98:513-524, 2001.
Fessler et al. The Journal of Biological Chemistry 277:31291-31302, 2002.
LaBaer J. Nature Biotechnology 21(9):976-977, 2003.
Futcher et al. Molecular and Cellular Biology. 19(11): 7357-7368, 1999.
Nagaraja et al. Oncogene. 25:2328-2338, 2006.
Waghray et al. Proteomics. 1:1327-1338, 2001.
Sagynaliev et al. Proteomics. 5:3066-3078, 2005.
Lederman et al. Molecular Immunology 28:1171-1181, 1991.
Oda et al. Virchows Arch. 430:99-105, 1997.
Sugg et al. Clinical Endocrinology 49: 629-637, 1998.
Toler et al. Am. J. Obstet. Gynecol. 194:e27-e31, 2006.
Berner et al. Histopathol. 42: 546-554, 2003.
Brooks et al. Am. J. Physiol. Renal Physiol. 284: F218-F228, 2003.
Li et al. Proc. Natl. Acad. Sci. USA 77:3211-3214, 1980.
Klein et al. Selection for Genes Encoding Secreted Proteins and Receptors.Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
Database Search, DNA Sequence Alignments [Blastn 2.2.1[Jul. 12, 2001], NCBI].
Database Search, Protein Sequence Alignments [Blastn 2.2.1 [Jul. 12, 2001], NCBI].
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 403-404, 453. New York: Garland Publishing.
Alberts, et al. 2002.Molecular Biology of the Cell 4th Edition, pp. 302, 363-364, 379, 435. New York: Garland Publishing.
The 1991 Boehringer Mannheim Biochemicals Catalog, p. 557, 1991.
Grimaldi, et al. 1989. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.Blood, 73(8):2081-2085.
Gygi, et al. 1999. Correlation between protein and mRNA abundance in yeast.Molecular and Cellular Biology, 19(3):1720-1730.
Hanna, et al. Aug. 1999. HER-2
eu breast cancer predictive testing.Pathology Associates Medical Laboratories.
Lewin, B. 1994. Oncogenes: Gene expression and cancer, Chap. 39, pp. 1196-1201.Genes V. New York: Oxford University Press.
Lewin, B. 1997. Regulation of Transcription, Chap. 29, pp. 847-848.Genes VI. New York: Oxford University Press.
Meeker, et al. 1990. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia.Blood, 76(2):285-289.
Meric, et al. 2002. Translation initiation in cancer: A novel target for therapy.Molecular Cancer Therapeutics, 1:971-979.
Singleton, et al. 1992. Clinical and pathologic significance of the c-erbB-2 (HER-2
eu) oncogene.Pathol. Annu., 1(27):165-190.
Zhigang, et al. 2004. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.World Journal of Surgical Oncology, 2:13.
2002-2003 Catalog & Technical Reference, New England BioLabs, Inc., p. 122.
Database Search, DNA Sequence Alignments [Blastn 2.2.1[Jul. 12, 2001], NCBI].
Database Search, Protein Sequence Alignments [Blastn 2.2.1[Jul. 12, 2001], NCBI].
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 1216-1217. New York: Garland Publishing.
Allman, et al. 1996. BCL-6 expression during B-cell activation.Blood, 87(12):5257-5268.
Anderson, et al. 1997. A comparison of selected mRNA and protein abundances in human liver.Electrophoresis, 18:533-537.
Chen, et al. 2002. Discordant protein and mRNA expression in lung adenocarcinomas.Molecular&Cellular Proteomics 1.4, pp. 304-313.
Fessler, et al. 2002. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase.The Journal of Biological Chemistry, 277(35):31291-31302.
Hanash, S. 2003. Making sense of microarray data to classify cancer.The Pharmacogenomics Journal, 3:308-311.
Hanash, S. Mar. 2005. Integrated global profiling of cancer.Nature Reviews, Applied Proteomics Collection, pp. 9-14.
Hancock, W. S. 2004. Do we have enough biomarkers?Journal of Proteome Research, 3(4):685.
Hyman, et al. 2002. Impact of DNA amplification on gene expression patterns in breast cancer.Cancer Research, 62:6240-6245.
Konopka, et al. 1986. Variable expression of the translocatedc-abloncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.Proc. Natl. Acad. Sci. USA, 83:4049-4052.
Ohara, et al. 2001. Directional cDNA library construction assisted by the in vitro recombination reaction.Nucleic Acids Research, 29(4):e22 p. 1-8.
Ørntoft, et al. 2002. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas.Molecular&Cellular Proteomics, 1:37-45.
Pollack, et al. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.PNAS, 99(20):12963-12968.
Tokunaga, et al. 2000. Application of quantitative RT-PCR using “TaqMan” technology to evaluate the expression of CK 18 mRNA in various cell lines.J. Exp. Clin. Cancer Res., 19(3):375-381.
Wang, et al. 1996. mRNA Differential display: Application in the discovery of novel pharmacological targets.Trends Pharmacol. Sci., 17(8):276-279.
Valle, et al. 2003. New approaches for biomarker discovery in lung cancer.Expert Rev. Mol. Diagn., 3(1):55-67.
Wang, et al. 2002. Novel candidate tumor marker genes for lung adenocarcinoma.Oncogene, 21:7598-7604.
Abe, et al. “An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.”Br J Cancer. Dec. 1, 2003;89(11):2104-9. (Abstract Only).
Ando, et al. “Selective apoptosis of natural killer-cell tumours by I-asparaginase.”Br. J. Haematol. Sep. 2005;130(6):860-8. (Abstract Only).
Aust, et al. “Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.”Thyroid. Oct. 1997;7(5):713-24. (Abstract Only).
Barnes, et al. “Expression of embryonic fibronectin isoform EIIIA parallels al
Goddard Audrey
Godowski Paul J.
Grimaldi J. Christopher
Gurney Austin L.
Wood William I.
Barnes Elizabeth M.
Blanchard David J.
Genentech Inc.
Knobbe Martens Olson & Bear LLP
Kresnak Mark T.
LandOfFree
Polypeptide encoded by a nucleic acid over-expressed in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptide encoded by a nucleic acid over-expressed in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide encoded by a nucleic acid over-expressed in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4048050